Indonesia Clinical Laboratory Market Outlook to 2026F: Ken Research

The report titled "Indonesia Clinical Laboratory Market Outlook to 2026F- Driven by Current Shortage, Widening Customer Base and Increasing Corporate Requirements for Clinical Testing" provides a comprehensive analysis of Clinical Laboratory Market in Indonesia. The report focuses on overall market size in terms of revenue generated by laboratories; Indonesia clinical laboratory market segmentation by Type of Independent Labs, type of payer, type of customers, types of tests, segmentation based on region and private hospitals. The report also covers the overall comparative landscape, trends and growth drivers, issues and challenge and government regulations. The report concludes with future projections and analyst recommendations highlighting the major opportunities and cautions.

Request For Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTI0MDQ5

Market Overview and Size
Indonesia Clinical Lab market was observed to grow with an augmenting growth rate in the review period 2016-2021. The Indonesia Clinical Lab market in terms of Revenue has increased at a positive CAGR of 11.5% during the review period 2016-2021. The growth was supported by increase in healthcare spending by aging population, expanding health insurance, growth in non-communicable disease and chronic diseases, rising disposable Income.

Market Segmentation of Data Center Industry
By Type of Labs: Clinical Laboratories can be recognized as Independent Labs, Private Hospital Labs and Public Hospital Labs. Public Hospital Labs have a majority in the Indonesian market followed by Private Hospital Labs.

By Number of Labs: The labs can be recognized as public or private labs basis their ownership. Private Labs dominate the market in Indonesia.
By Type of Private Independent Labs: In Indonesia, organized labs dominated the market share followed by unorganized labs. Majority of the organized labs are located in Java and Jakarta. This has been facilitated by increase in expenditure on health services, as people have become more health conscious.

By Type of Payer: Corporates have accounted for the largest share of the number of tests in Indonesia. As the growing Indonesian workforce has led to an increase in corporate clients for pre-employment checks and annual health checks, more companies are engaging with private medical labs.

By Type of Consumer (Basis Number of Tests): Majority of the patients who are consumer to these laboratories come through doctor referrals with majority market share based on the number of tests. Walk-ins and corporate clients respectively follow this.

By Type of Tests: On the basis of type of tests the market is split between Routine, Esoteric and Non-laboratory tests. The most popular in the market are Routine tests. The non-laboratory tests account for a relatively small share of lab tests due to the additional licenses required to carry them out. Thus, laboratories are reluctant to do those tests.

By Type of Routine Tests: The routine tests have different categories of tests. The leader in this category is CBC followed by Basic Metabolic Panel.
By Esoteric tests: The esoteric tests have different categories of tests. The leader in this category is endocrine followed by infectious disease.
By Region: Java, Jakarta and Bali have high rate of urbanization and more affluent population, which has created greater access and demand for private clinical laboratory testing services.
By Private Hospital Labs: Private hospitals either have their own in-house labs or have a tie-up with a third party lab to accommodate their labs. In Indonesia in-house laboratories have a majority.
Competitive Landscape

The market is highly concentrated with the top private independent players being Prodia and Diagnos. Market is dominated by Prodia (PRDA). Kimia farma is the 2nd major player and Bio medika is the least contributor. CITO was designated by the Ministry of Health to be one of the laboratories for examining the coronavirus. This helped to be recognized across the region and thereby sustain footprints in the market. To capture the shift, industry leaders have started to implement initiatives such as retailer partnering, offering home testing, and enhancing engagement with patients through digital presence.

Future Outlook and Projections
Over the forecast period 2022-2026F, the Indonesia Clinical Lab Market Revenue is further anticipated to increase by year 2026F, thus showcasing a CAGR of 12.5%. It is expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories.

Players, Investing to increase its testing capabilities and has adopted several advanced tests and technologies introduced in the global market, particularly specialized tests. Further, the major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. This will further lead to increase in market share in the overall Indonesia clinical laboratory market.

Key Segments Covered of Clinical Laboratory
By Type of Labs
Independent Labs
Private Hospital Labs
Public Hospital Labs
By Number of Labs
Private Labs
Public Labs
By Type of Private Independent Labs:
Organised
Unorganised
By Type of payor:
Corporates
Out-Of-Pocket
Private Insurance
BPJS Badan Penyelenggara Jaminan Sosial (Social Insurance Administration Organization)

By Type of Customer:
Doctor Referral
Corporates
Walk-Ins
External referrals
Online Referrals
By Type of Tests:
Routine
Esoteric
Non-Laboratory
By Type of routine tests:
CBC
Basic Metabolic Panel
A1C
Others
By Type of Esoteric Tests
Endocrine
Infectious disease
Allergic Disease
Oncology
Others

By Private Hospital Labs
In-House
Third Party
By Region
Greater Jakarta
West Java
East Java, Bali, Nusa
Aceh and North Sumatera
Central Java
Central Sumatera
Sulawesi and Maluku
Kalimantran
Others
Key Target Audience
Clinical Laboratory companies
Organised Clinical Laboratories
Unorganised Clinical Laboratories
Private Hospitals

Private Equity and Venture Capitalist
Industry Associations
Technology providers
Time Period Captured in the Report:
Historical Period - 2016-2021
Forecast Period - 2021-2026
Companies Covered:
Organised Laboratory Companies:
Prodia
Diagnos
Pathlab
Pramita
Ultra Medica
Kimia Farma
Prima Medika
Cito
Parahita
ABC Labs
Bio Medika

Key Topics Covered in the Report
Overview of Indonesia Clinical Laboratory Market
Ecosystem of Major Entities in Indonesia Clinical Laboratory Market
Business Cycle and Genesis of Indonesia Clinical Laboratory Market
Indonesia Clinical Laboratory Market Size, 2016-2021
Indonesia Clinical Laboratory Market Segmentations
Competition Analysis: Indonesia Clinical Laboratory Companies
SWOT Analysis in Indonesia Clinical Laboratory Market
Growth Drivers and Restraints in Indonesia Clinical Laboratory Market
Technological Advancements in Indonesia Clinical Laboratory Market
Impact of COVID19 in Malaysia Property Classified Market

Key Trends in Indonesia Clinical Laboratory Market
Outlook and Future Projections for Indonesia Clinical Laboratory Market
Recommendations / Success Factors
Research Methodology
Appendix

For More Information on the Research Report, refer to below links: -
https://www.kenresearch.com/healthcare/diagnostics/indonesia-clinical-laboratory-market-outlook-to-2026/524049-91.html

Related Reports by Ken Research
https://www.kenresearch.com/healthcare/diagnostics/vietnam-diagnostic-lab-market/143767-91.html

https://www.kenresearch.com/healthcare/diagnostics/indonesia-clinical-lab-market/143543-91.html

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
support@kenresearch.com
+91-9015378249

Follow Us
LinkedIn | Instagram | Facebook | Twitter | YouTube

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a research based management consulting company. We provide strategic consultancy to aid clients on critical business perspective: strategy, marketing, organization, operations and technology transformation, advanced analytics, corporate finance, mergers & acquisitions and sustainability across all industries and geographies. We provide business intelligence and operational advisory across 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Some of top consulting companies and Market leaders seek our intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.